جست‌وجوی استاد و پژوهشگر

Wei Chaoمشاهده پروفایل

استاد

• Sepsis
• Trauma
• Ischemic Myocardial Injury
• +۷ مورد دیگر

Wei Chao, MD, PhD , is a Professor at the University of Maryland School of Medicine with primary appointments in Anesthesiology and secondary appointments in Physiology . He serves as Vice Chair for Translational Research and Co-Director of the STAR Center . MD from Hunan Medical College, China PhD in Biochemistry, University of Texas Postdoc at University of California, San Diego Dr. Chao's research spans sepsis , trauma , and ischemic myocardial injury , focusing on innate immunity , microRNA , and bioinformatics . His work integrates mouse genetics , physiology , and machine learning to identify biomarkers and therapeutic targets. Recent publications highlight his team's discoveries in extracellular RNA sensing, TLR7 signaling , and coagulopathy in critical illnesses. His 15 most recent articles address topics like sepsis-induced organ injury, miRNA-based diagnostics, and inflammation mechanisms. Dr. Chao has received prestigious awards including the R35 Maximizing Investigators’ Research Award (NIGMS, 2021), Frontiers in Anesthesia Research Award (IARS, 2018-2021), and Colin Mackenzie & Cristina Imle Mentoring Prize (2021). He has been continuously funded by NIH for over 20 years, DoD since 2017, and holds grants from the Air Force and National Science Foundation .

Fabian Gaesslerمشاهده پروفایل

استادیار

• Innovation Economics
• Economics of Science
• Empirical Industrial Organization
• +۸ مورد دیگر

Fabian Gaessler is an Assistant Professor at the Universitat Pompeu Fabra (Department of Economics and Business) and an Affiliated Research Fellow at the Max Planck Institute for Innovation and Competition since 2022. He also serves as an Affiliated Professor at the Barcelona School of Economics and previously held academic roles at IESE Business School (2019) and Technical University of Munich (2018–2019). Education: Doctoral Studies (2013–2015) at Max Planck Institute for Innovation and Competition Postgraduate Law and Economics (2010–2013) at International Max Planck Research School M.Sc. in Organization, Management and Governance (2009–2010) at London School of Economics Honors Degree in Technology Management (2008–2011) at Center for Digital Technology and Management, Munich B.Sc. in Business Administration (2005–2009) at LMU Munich and University of California, Santa Barbara Research Interests focus on innovation economics , patent policy , and AI applications in strategic decision-making . His work bridges empirical industrial organization and technology management , with key contributions on patent enforcement, data exclusivity, and human-AI collaboration in innovation. Key Article Trends include: Patent oppositions and follow-on innovation AI as a training tool in strategic environments Market exclusivity impacts on pharmaceutical R&D Physical capital shocks in scientific productivity Bifurcated patent litigation systems Scientific quality and patent value linkages Scientific Awards : 2017: Otto Hahn Medal of the Max Planck Society Advising and Grants : While direct student advisement is not explicitly listed, Gaessler has collaborated extensively with scholars like Dietmar Harhoff, Karin Hoisl, and Henning Piezunka. His research has been supported by institutions including the Max Planck Society, European Commission, and ZEW. Labs and Teams : Affiliated with the Innovation and Entrepreneurship Research group at Max Planck Institute for Innovation and Competition. His work involves cross-institutional collaborations with European patent litigation experts and biomedical research teams.

Milan K. Bagchiمشاهده پروفایل

استاد

• Endocrinology
• Reproductive Biology
• Signal Transduction
• +۴ مورد دیگر

Milan K. Bagchi is the Deborah Paul Professor of Molecular & Cellular Biology and Director of the School of Molecular & Cellular Biology at the University of Illinois Urbana-Champaign. He also holds a joint appointment as Professor of Molecular & Integrative Physiology. His research focuses on steroid hormone signaling mechanisms in reproduction and disease, particularly estrogen and progesterone regulation of embryo implantation and cancer biology. Education: B.S. (1976), M.S. (1979) from University of Calcutta, India; Ph.D. (1984) from University of Nebraska; Postdoc (1985–89) at Baylor College of Medicine. Research interests include endocrinology, reproductive biology, and signal transduction. Key areas: hormonal regulation of implantation, gene networks in fertility, and molecular basis of hormone-dependent cancers. His lab uses mouse models and genomic approaches to study uterine function and hormonal pathways. Notable awards: Romano Professorial Scholar and University Scholar. Recent work highlights include studies on phthalate impacts on uterine physiology (2023), hypoxia-driven embryo implantation mechanisms (2025), and decidualization pathways. His publications span hormone signaling, environmental toxin effects, and cell communication in reproductive systems. Awards and honors include roles as a distinguished scholar and contributions to biomedical research. Collaborations extend to institutions like the Carle Illinois College of Medicine and the Carl R. Woese Institute of Genomic Biology.

Shana Stoddardمشاهده پروفایل

دانشیار

• Autoimmune disorders
• Protein engineering
• Computational chemistry
• +۶ مورد دیگر

Dr. Shana Stoddard is an Associate Professor of Chemistry at Rhodes College, where she leads the Molecular Immunotherapeutics Research (MIR) lab. Her research program focuses on improving patient outcomes with autoimmune disorders, cancer, neurological disorders, and coronaviruses through protein engineering, computational chemistry, and rational drug design. Dr. Stoddard received her educational training from: Postdoctoral Researcher at St. Jude Children's Research Hospital (Diagnostic Imaging) Ph.D. in Chemistry and Biochemistry from University of Mississippi M.Ed. in Curriculum and Instruction (emphasis Special Education) from Freed-Hardeman University B.S. in Chemistry from Prairie View A&M University Dr. Stoddard's research interests span multiple areas of biomedical science with a focus on therapeutic development. Her work in autoimmune disorders centers on primary membranous nephritis (PMN), where she develops auto-antibody-specific inhibitors and antigen-specific therapies. In cancer research , she focuses on designing selective histone deacetylase (HDAC) inhibitors for various cancer types, particularly targeting HDAC8 for neuroblastoma treatment. Her lab also works on neurological disorders , developing HDAC4 inhibitors for Huntington's disease and glioblastoma. During the COVID-19 pandemic, her lab pivoted to coronavirus antiviral development , creating peptide-based fusion inhibitors and protease inhibitors. Additionally, Dr. Stoddard is deeply committed to diversity and equity in STEM education , developing pedagogical approaches to create more inclusive classrooms. Analysis of Dr. Stoddard's recent publications reveals a consistent focus on structure-based drug design across multiple therapeutic areas. Her work employs computational chemistry approaches to model protein structures and design inhibitors with improved selectivity. A significant portion of her research targets histone deacetylases (HDACs), with emphasis on achieving isozyme selectivity among the 18 different HDAC enzymes. Her lab has made contributions to understanding protein structures involved in autoimmune kidney diseases and developed computational models of previously uncharacterized proteins. Dr. Stoddard has received numerous prestigious awards recognizing both her research and mentorship: 2025 – LMI Mellon Fellow 2024 – Lloyd N Ferguson Young Scientist Award from NOBCChE 2024 – Sigma Xi, The Scientific Research Honor Society inductee 2024 – Ruth Kirschstein Diversity in Science Award from ASBMB 2023 – Tyrone Mitchell Mentor-on-the-Map Award from NOBCChE 2023 – Silvia Ronco Innovative Mentor Award from CUR Chemistry 2022 – Henry C. McBay Outstanding Teaching Award from NOBCChE 2021 – Outstanding Mentor of the year Award CUR Health Sciences (Early Career Stage) 2021 – Accessibility and Inclusivity Advocate of the Year: Campus Life Award (Rhodes College) Dr. Stoddard is renowned for her exceptional mentorship of undergraduate researchers, particularly from underrepresented groups in STEM. She established the STEM Cohort Mentoring program at Rhodes in 2017 to support diverse students pursuing STEM careers. Her lab has produced numerous undergraduate co-authors on peer-reviewed publications across multiple disciplines. She has successfully guided many students into medical schools and graduate programs. Dr. Stoddard has secured competitive funding for her research, including participation in the Project Kaleidoscope STEM Leadership Institute held by the American Association of Colleges & Universities. The Molecular Immunotherapeutics Research (MIR) lab at Rhodes College is a vibrant research environment where undergraduate students work alongside Dr. Stoddard on cutting-edge biomedical research. The lab currently pursues four major research projects: 1) Protein Engineering and Development of Antigen Specific Therapeutics for Autoimmune Disorders; 2) Modeling and Investigation of Structure and Function Relationships of Unsolved Protein Structures; 3) Design, Synthesis, and Biological Testing of Novel Therapeutic Compounds for Cancer, Autoimmune, and Neurological Disorders; and 4) Development of Broad-Spectrum Coronavirus Antivirals. The MIR lab collaborates with researchers at institutions including Boston University Medical College, University of Mississippi, and St. Jude Children's Research Hospital.

David Lynnمشاهده پروفایل

استاد

• Systems immunology
• Microbiota
• Vaccines
• +۱۲ مورد دیگر

Professor David Lynn is a leading academic in Systems Immunology at Flinders University and Scientific Director of the SA Genomics Centre, with affiliations to the South Australian Health and Medical Research Institute (SAHMRI) and College of Medicine and Public Health. He has held these positions since 2020 and 2019, respectively. BA (Trinity College Dublin, Genetics; 2000) MSc (University of Ottawa, Bioinformatics & Bacterial Genomics; 2001) PhD (University College Dublin, Immunology; 2004) His research interests focus on systems immunology, exploring how microbes (pathogenic and commensal) modulate immune responses in contexts such as infection, vaccination, and cancer therapies. He integrates computational modeling, bioinformatics, and preclinical mouse models to advance understanding of trained immunity and vaccine mechanisms. Recent research trends show his work spans vaccine responses, microbiota interactions, and genomics. Notable projects include the Gates Foundation-funded BRACE trial on BCG vaccine effects against COVID-19 and NHMRC-funded studies on microbiota's role in vaccination. His scientific awards include: 2023-2028: BioPlatforms Australia National Research Infrastructure funding 2023-2024: GPN Vaccines Collaborative Research Agreement 2023-2028: South Australian Government NCRIS Co-investment Grant 2023-2026: NHMRC Ideas Grant on gut microbiota and vaccine responses 2023-2025: ARC Discovery Project on androgen receptor and lipid metabolism He supervises research teams and contributes to clinical studies and genomics infrastructure development, with grants exceeding $30 million from NHMRC, GSK, and Cancer Australia. His work aligns with UN SDGs in health and well-being, reduced inequalities, and industry innovation.

Joyce Gonzalesمشاهده پروفایل

استاد

• Pulmonary Medicine
• Critical Care Medicine
• Hematology
• +۲ مورد دیگر

Dr. Joyce Gonzales is a Professor in the Department of Medicine (Pulmonary Division) at the Medical College of Georgia. She holds an MD from the University of Health Sciences (2002) and a BSN from Excelsior College (1998), with certifications in ACLS instruction (2007), Georgia state physician licensure (2009), and American Board of Internal Medicine (2006). Her research focuses on pulmonary and vascular pathophysiology, including bacterial toxin mechanisms in lung injury, endothelial barrier regulation in sickle cell disease, and novel anticoagulant therapies. Key areas include: Molecular pathways of pneumolysin-induced endothelial damage Thrombin-PAR signaling in vascular permeability Pulmonary complications of hematological disorders Therapeutic interventions for acute chest syndrome She has received multiple honors for service excellence: William Beaumont Army Medical Center Humanitarian Award (2003) Department of the Army Commander’s Award for Civilian Service (1999) Department of the Army Service Recognition (1996) Larimer County Health Department Service Award (1993) Dr. Gonzales teaches core medical courses including RMED 5000 (Medicine), GMED 5034 (Medical Critical Care), and RPUL 5000 (Pulmonary & Critical Care).

Aurora Martinezمشاهده پروفایل

استاد

• Structural Biology
• Drug Discovery
• Neurometabolic Disorders
• +۷ مورد دیگر

Aurora Martinez is a Professor in the Department of Biomedicine at the University of Bergen, Faculty of Medicine. She leads the Biorecognition research group, focusing on the structural and functional aspects of biomolecules in neurometabolic disorders such as phenylketonuria (PKU) and dopamine synthesis defects. She is also a partner in the KG Jebsen Centre for Neuropsychiatric Disorders and a Toppforsk-funded project on the Arc protein, a master regulator of synaptic plasticity. Position: Professor Institution: University of Bergen Department: Department of Biomedicine Research Group: Biorecognition Email: aurora.martinez@uib.no Her research integrates structural biology, molecular recognition, and drug discovery to develop therapeutic strategies for genetic and neurodegenerative diseases. Key areas include tyrosine hydroxylase regulation, mitochondrial dysfunction in dopaminergic cells, and neurotransmitter transport mechanisms. She employs biochemical, cellular, and computational approaches to understand disease mechanisms and identify novel therapeutics. The recent publications (2023–2025) reflect a strong trend toward understanding dopamine-related pathways, protein stabilization, and therapeutic interventions in Parkinsonism and related disorders. Themes include chaperone-mediated protein stabilization, high-throughput screening for VMAT2 modulators, and computational tools for drug discovery. The work combines experimental validation with translational applications in neurodegenerative models. She has supervised multiple Master’s students, including Md. Ekhtear Mahmud, Sofie Breisnes Wormdahl, and Kristine Kippersund Brokstad, indicating active mentorship and training roles. Her involvement in large-scale collaborative projects highlights leadership and interdisciplinary engagement. While no specific awards are listed, her participation in prestigious programs like Toppforsk and the KG Jebsen Centre underscores recognition and funding success. She has no listed grants explicitly, but project affiliations suggest competitive funding support. Her research group maintains strong technical capabilities in protein analysis, cellular screening, and structural modeling. The Martinez Lab is actively involved in both fundamental and applied research, with future directions likely to expand into gene therapy, precision medicine for metabolic disorders, and neuroprotective strategies.

• Cellular & Systems Neuroscience
• Theoretical Neuroscience & Technical Applications
• Biomedical Neuroscience
• +۸ مورد دیگر

Ali Ertürk is a Professor at Helmholtz Zentrum München, serving as Director of the Institute for Tissue Engineering and Regenerative Medicine (iTERM). His work bridges cutting-edge technology and biomedical innovation, focusing on tissue clearing, spatial-omics, and AI-driven analysis to map biological systems at unprecedented resolution. His research spans three primary areas: Cellular & Systems Neuroscience Theoretical Neuroscience & Technical Applications Biomedical Neuroscience Keywords include tissue clearing, organoids, and neurodegeneration. Selected publications highlight advancements in vDISCO imaging, SHANEL protocols, and AI applications for cancer and neurodegenerative diseases. Graduated students include Dr. Chenchen Pan and Dr. Ruiyao Cai.

Maria Roblesمشاهده پروفایل

استاد

• Chronobiology
• Circadian Rhythms
• Sleep Research
• +۹ مورد دیگر

Prof. Dr. Maria Robles is a full Professor and Head of the Systems Chronobiology research group at the Institute of Medical Psychology, Ludwig-Maximilians-Universität München (LMU), Faculty of Medicine. She leads a dynamic research lab focused on circadian rhythms, sleep, and their molecular underpinnings in health and disease, using cutting-edge quantitative proteomics and mass spectrometry as core methodologies. Her research spans multiple domains, including Circadian regulation of metabolism Molecular mechanisms of sleep and synaptic function Circadian clock dysfunction in diseases such as pancreatic cancer Development of novel proteomic methods (e.g., DIA, multi-omics integration) The analysis of her 15 most recent publications reveals a strong trend toward integrating proteomics with systems biology to dissect temporal dynamics in mammalian tissues. Her work frequently explores post-translational modifications, particularly phosphorylation and ubiquitination, in circadian and sleep contexts, with increasing translational focus on cancer biology and therapeutic targeting. She actively mentors PhD students and postdoctoral researchers, contributing to training the next generation of scientists in chronobiology and proteomics. Her lab is affiliated with the Biomedical Center (BMC) at LMU and is equipped with state-of-the-art instrumentation, including Orbitrap and Q-Exactive mass spectrometers, supported by DFG and LMU funding. She collaborates extensively, notably with Dieter Saur (TUM) on pancreatic cancer research.

Lubo Zhangمشاهده پروفایل

استاد

• Perinatal Biology
• Hypoxia Research
• Vascular Pharmacology
• +۴ مورد دیگر

Lubo Zhang, PhD, is a Professor in the Pharmacology Division at Loma Linda University School of Medicine, serving as Director of the Center for Perinatal Biology. With over 386 publications and 13 NIH-funded projects, his work focuses on hypoxia adaptation, epigenetic programming, and maternal-fetal cardiovascular interactions. Education: PhD in Biology from Iowa State University (1990) Research Interests: Zhang's research investigates hypoxia-induced vascular dysfunction, microRNA regulatory mechanisms in pulmonary hypertension, and epigenetic modifications from prenatal exposures. His team explores calcium signaling pathways in uterine artery adaptation and mitochondrial oxidative stress in pregnancy complications. Recent Publications: 2024-2025 work highlights hypoxia's role in maternal vascular tone, microRNA-210's regulation of mtROS in pulmonary hypertension, and epigenetic consequences of maternal e-cigarette exposure. Key findings connect prenatal nicotine to adult cardiovascular vulnerability and identify TET2 as a critical mediator of hypoxia responses. Awards: Recipient of the Loma Linda University Adventist Health Sciences Center Centennial Vanguard Award (2006) Funding: Research funded by NIH (NICHD, NHLBI), National Science Foundation (MRI acquisition), and institutional grants. Projects include multi-omics approaches to fetal hypoxia adaptation and development of advanced imaging techniques for neonatal brain injury.

Uma Srikanthمشاهده پروفایل

عضو هیئت علمی

• Molecular Biology
• Cell Biology
• Neurodegenerative Diseases
• +۷ مورد دیگر

Uma Srikanth is a Professor of Instruction and Assistant Department Head/Undergraduate Faculty Advisor in the Department of Biological Sciences at the University of Texas at Dallas, within the School of Natural Sciences and Mathematics. She plays a key role in undergraduate education and academic leadership, actively contributing to curriculum development, accreditation, and transfer student support. Her educational background includes a Ph.D. in Molecular and Cell Biology from the University of Texas at Dallas (1999), an M.S. in the same field from UTD (1995), and both an M.S. and B.Sc. in Biochemistry from the University of Madras. M.S. - Biochemistry, University of Madras B.Sc. - Biochemistry, University of Madras M.S. - Molecular and Cell Biology, University of Texas at Dallas (1995) Ph.D. - Molecular and Cell Biology, University of Texas at Dallas (1999) Her research interests center on molecular and cellular mechanisms of neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS). She has extensively studied mutant hSOD1 using transgenic mouse models to understand disease pathology. Additional interests include RNA editing in mitochondrial genes and broader topics in cell and molecular biology, with a strong emphasis on undergraduate training and professional preparation in the life sciences. Although no publications are listed in the provided text, her work has focused on modeling ALS and analyzing molecular changes in transgenic systems, suggesting a research trajectory in experimental neurobiology and molecular genetics. She has been recognized for her teaching excellence with the Dean's Teaching Award from the School of Natural Sciences and Mathematics in 2016. Dean's Teaching Award - NSM [2016] Uma Srikanth is deeply involved in academic service and leadership. She has served on multiple committees including the Academic Senate (2022–2026), Co-Chair of the Workload Policy Committee in Biological Sciences (2023–2025), and the Undergraduate Education Committee. She contributes to state-level initiatives through the Texas Higher Education Coordinating Board, supporting transfer pathways in biology. Her work in assessment supports accreditation efforts, and she has held leadership roles in core curriculum reform at the university level. She has no listed laboratory or research team in the provided material, but her prior research was conducted in the Department of Neurology at the University of Texas Southwestern Medical Center.

Katelyn Byrneمشاهده پروفایل

استادیار

• Pancreatic Cancer
• Immunotherapy
• Tumor Microenvironment
• +۴ مورد دیگر

Katelyn Byrne is an Assistant Professor at Oregon Health and Science University (OHSU) in the Cell, Developmental and Cancer Biology department, affiliated with the Knight Cancer Institute and Brenden-Colson Center for Pancreatic Care. Her research focuses on the immunobiology of pancreatic cancer, particularly mechanisms bridging innate and adaptive immunity to enhance immunotherapy efficacy. Education: B.A. (2007) from Boston University, Ph.D. (2013) from Dartmouth College, and postdoctoral training as a Senior Parker Fellow. Her work leverages genetically engineered mouse models of pancreatic cancer to study tumor microenvironment dynamics , with clinical translation in immunotherapy trials. Key contributions include CD40 agonism for CD4+ T cell-mediated tumor rejection, immune checkpoint blockade synergy, and spatial transcriptomics for infiltrate heterogeneity. Recent articles (2024) highlight machine learning in immune profiling and MHC class I-deficient tumor targeting. Dr. Byrne is a recipient of the American Cancer Society Post-doctoral Fellowship and Senior Parker Fellowship . She mentors graduate students Margaret Haerr and Yi Zhang in her lab, which collaborates across OHSU’s cancer research centers. Current projects aim to develop novel immunotherapy combinations and T cell infiltration strategies for pancreatic cancer.

• Neuroscience
• Pharmaceutical Sciences
• Drug Delivery
• +۷ مورد دیگر

Yijun Pan is a Senior Research Fellow in the Department of Neuroscience at the Monash Institute of Pharmaceutical Sciences (MIPS), Monash University. He holds an adjunct lecturer position at Tohoku University, Japan. His research focuses on the role of Fatty Acid-Binding Proteins (FABPs) in immunometabolism and drug delivery in neurodegenerative diseases such as Alzheimer’s disease and Motor Neuron Disease. Bachelor of Pharmacy, Monash University PhD in Pharmaceutical Sciences, Monash University, supervised by Associate Professor Joseph Nicolazzo, Professor Christopher Porter, and Professor Martin Scanlon Dr Pan’s research interests center on the molecular mechanisms of FABPs in brain endothelial cells, microglia, and astrocytes, particularly in the context of neuroinflammation and lipid metabolism. His work explores how these proteins influence drug transport across the blood-brain barrier and contribute to disease progression in dementia and motor neuron disorders. He employs in vitro and in vivo models to study immunometabolic pathways and optimize therapeutic delivery. His recent publications demonstrate a strong trend in neuropharmacology, focusing on blood-brain barrier function, fatty acid transport, neuroinflammation, and cognitive outcomes in animal models. Key themes include the modulation of drug transporters, the role of ion channels in neuroprotection, and immune cell involvement in neurodegeneration. American Chemical Society Editors’ Choice Award, Molecular Pharmaceutics (2015) Best Oral Presentation Award, 8th Victorian Association of Chinese PhD Students and Young Scholars Research Symposium (2014) Honourable Geoffrey Connard AM Student Travelling Scholarship (2013) JSPS Postdoctoral Research Fellowship (2018) Neil Naismith Award (2012) Dr Pan is actively involved in mentoring and supervision, contributing to Honours and PhD projects at MIPS. He has served as a Chief Investigator on multiple competitive grants, including those from Dementia Australia and FightMND. He regularly engages in peer review for journals such as Molecular Pharmaceutics , Diagnosis , and Biomolecules , and has presented his work at institutions including RMIT and the National University of Singapore. He is a key member of the Drug Delivery, Disposition and Dynamics Theme at MIPS and collaborates internationally, particularly with Tohoku University. His research is supported by significant funding from the Japan Society for the Promotion of Science, Dementia Australia, and FightMND.

• Skeletal Muscle Regeneration
• Neurovascular Tissue Regeneration
• Biomaterials for Soft Tissue Applications
• +۳ مورد دیگر

Aaron B. Morton is an Assistant Professor in Kinesiology and Sport Management at Texas A&M University, directing the Soft Tissue Regeneration and Applied Biomaterials (STRAB) Laboratory. He holds a Ph.D. in Exercise Physiology from the University of Florida (2018) and prior degrees from the University of West Florida and Harding University. His research focuses on skeletal muscle regeneration, neurovascular tissue interactions, and inorganic biomaterials for soft tissue applications, with emphasis on biomaterial development for muscle injuries and dystrophy treatment. Key research grants include a $495,972 TAMU Advancing Discovery award (2023–2025) and an NIH Loan Repayment Award for Pediatric Research (2020–2022). He has authored patents on biomaterials for stem cell dispersion and muscle treatment methods. Teaching includes KINE427 (Therapeutic Principles) and KINE433 (Exercise Physiology). Notable awards include the Microcirculatory Society Pappenheimer Postdoctoral Travel Award (2022) and multiple poster awards at physiology conferences. His work bridges biomechanical engineering with clinical applications, emphasizing translational research in regenerative therapies.

• Vascular Biology
• Aging and Exercise Physiology
• Cardiovascular Disease
• +۳ مورد دیگر

Christopher Woodman is an Associate Professor in the Department of Health and Kinesiology at Texas A&M University and Director of the Vascular Biology Laboratory. He joined Texas A&M in 2006, specializing in vascular aging and exercise physiology. His research focuses on how aging and exercise affect skeletal muscle blood vessels, particularly mechanisms underlying cardiovascular disease risk in the elderly. Education: Ph.D., Physiological Sciences, University of Arizona (1995) M.S., Exercise Science, University of Arizona (1989) B.A., Biology, Colgate University (1986) Research Interests: Dr. Woodman investigates aging’s impact on vascular function, including arterial stiffness, endothelial dysfunction, and how exercise mitigates these effects. His lab uses mouse models and human studies to explore integrin signaling, smooth muscle mechanics, and exercise-induced adaptations. Articles Trends: Recent work highlights aging’s effects on integrin-mediated contractility, genetic influences on vasomotor function, and exercise’s role in reversing endothelial dysfunction. Key themes include mechanotransduction, vascular stiffness, and genotype-specific vascular responses. Scientific Awards: Association of Former Students Distinguished Teaching Award (2021) Collins Faculty Fellow (2011) NIH Research Career Development Award (2001) Advising & Grants: Advised five doctoral students since 2010. Active grants include NIH-funded studies on vascular smooth muscle aging (2017–2022) and integrin function in aged arteries (2019–2021). Collaborates on projects exploring exercise’s mechanical benefits and genetic influences on vascular health. Labs/Teams: Leads the Vascular Biology Laboratory, focusing on arterial aging mechanisms and exercise interventions. Collaborates with researchers at the Texas A&M Health Science Center and the American Heart Association.